Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 100 entries
Sorted by: Best Match Show Resources per page
Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission.

Journal of neuromuscular diseases

Chaouch A, Porcelli V, Cox D, Edvardson S, Scarcia P, De Grassi A, Pierri CL, Cossins J, Laval SH, Griffin H, Müller JS, Evangelista T, Töpf A, Abicht A, Huebner A, von der Hagen M, Bushby K, Straub V, Horvath R, Elpeleg O, Palace J, Senderek J, Beeson D, Palmieri L, Lochmüller H.
PMID: 26870663
J Neuromuscul Dis. 2014;1(1):75-90. doi: 10.3233/JND-140021.

BACKGROUND AND OBJECTIVE: Congenital myasthenic syndromes are rare inherited disorders characterized by fatigable weakness caused by malfunction of the neuromuscular junction. We performed whole exome sequencing to unravel the genetic aetiology in an English sib pair with clinical features...

Cite
Chaouch A, Porcelli V, Cox D, et al. Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission. J Neuromuscul Dis. 2014;1(1):75-90doi: 10.3233/JND-140021.
Chaouch, A., Porcelli, V., Cox, D., Edvardson, S., Scarcia, P., De Grassi, A., Pierri, C. L., Cossins, J., Laval, S. H., Griffin, H., Müller, J. S., Evangelista, T., Töpf, A., Abicht, A., Huebner, A., von der Hagen, M., Bushby, K., Straub, V., Horvath, R., Elpeleg, O., Palace, J., Senderek, J., Beeson, D., Palmieri, L., & Lochmüller, H. (2014). Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission. Journal of neuromuscular diseases, 1(1), 75-90. https://doi.org/10.3233/JND-140021
Chaouch, Amina, et al. "Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission." Journal of neuromuscular diseases vol. 1,1 (2014): 75-90. doi: https://doi.org/10.3233/JND-140021
Chaouch A, Porcelli V, Cox D, Edvardson S, Scarcia P, De Grassi A, Pierri CL, Cossins J, Laval SH, Griffin H, Müller JS, Evangelista T, Töpf A, Abicht A, Huebner A, von der Hagen M, Bushby K, Straub V, Horvath R, Elpeleg O, Palace J, Senderek J, Beeson D, Palmieri L, Lochmüller H. Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission. J Neuromuscul Dis. 2014;1(1):75-90. doi: 10.3233/JND-140021. PMID: 26870663; PMCID: PMC4746751.
Copy Download .nbib Format: NLM
Teratogenic potency of valproate analogues evaluated by quantitative estimation of cellular morphology in vitro.

Toxicology in vitro : an international journal published in association with BIBRA

Berezin V, Kawa A, Bojic U, Foley A, Nau H, Regan C, Edvardsen K, Bock E.
PMID: 20650240
Toxicol In Vitro. 1996 Oct;10(5):585-94. doi: 10.1016/s0887-2333(96)00049-5.

To develop a simple prescreening system for teratogenicity testing, a novel in vitro assay was established using computer assisted microscopy allowing automatic delineation of contours of stained cells and thereby quantitative determination of cellular morphology. The effects of valproic...

Cite
Berezin V, Kawa A, Bojic U, et al. Teratogenic potency of valproate analogues evaluated by quantitative estimation of cellular morphology in vitro. Toxicol In Vitro. 1996;10(5):585-94doi: 10.1016/s0887-2333(96)00049-5.
Berezin, V., Kawa, A., Bojic, U., Foley, A., Nau, H., Regan, C., Edvardsen, K., & Bock, E. (1996). Teratogenic potency of valproate analogues evaluated by quantitative estimation of cellular morphology in vitro. Toxicology in vitro : an international journal published in association with BIBRA, 10(5), 585-94. https://doi.org/10.1016/s0887-2333(96)00049-5
Berezin, V, et al. "Teratogenic potency of valproate analogues evaluated by quantitative estimation of cellular morphology in vitro." Toxicology in vitro : an international journal published in association with BIBRA vol. 10,5 (1996): 585-94. doi: https://doi.org/10.1016/s0887-2333(96)00049-5
Berezin V, Kawa A, Bojic U, Foley A, Nau H, Regan C, Edvardsen K, Bock E. Teratogenic potency of valproate analogues evaluated by quantitative estimation of cellular morphology in vitro. Toxicol In Vitro. 1996 Oct;10(5):585-94. doi: 10.1016/s0887-2333(96)00049-5. PMID: 20650240.
Copy Download .nbib Format: NLM
Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial.

ISRN oncology

Engebraaten O, Edvardsen H, Løkkevik E, Naume B, Kristensen V, Ottestad L, Natarajan V.
PMID: 22666610
ISRN Oncol. 2012;2012:176789. doi: 10.5402/2012/176789. Epub 2012 May 14.

In patients with metastatic breast cancer, taxane treatment demonstrates activity but is not curative. Targeted treatment modalities are therefore necessary in order to improve outcomes in this group. A randomized placebo-controlled phase II trial was initiated to evaluate effect...

Cite
Engebraaten O, Edvardsen H, Løkkevik E, et al. Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial. ISRN Oncol. 2012;2012:176789doi: 10.5402/2012/176789.
Engebraaten, O., Edvardsen, H., Løkkevik, E., Naume, B., Kristensen, V., Ottestad, L., & Natarajan, V. (2012). Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial. ISRN oncology, 2012176789. https://doi.org/10.5402/2012/176789
Engebraaten, Olav, et al. "Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial." ISRN oncology vol. 2012 (2012): 176789. doi: https://doi.org/10.5402/2012/176789
Engebraaten O, Edvardsen H, Løkkevik E, Naume B, Kristensen V, Ottestad L, Natarajan V. Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial. ISRN Oncol. 2012;2012:176789. doi: 10.5402/2012/176789. Epub 2012 May 14. PMID: 22666610; PMCID: PMC3361199.
Copy Download .nbib Format: NLM
Use of alcohol and drugs among health professionals in Norway: a study using data from questionnaires and samples of oral fluid.

Journal of occupational medicine and toxicology (London, England)

Edvardsen HM, Karinen R, Moan IS, Oiestad EL, Christophersen AS, Gjerde H.
PMID: 24612541
J Occup Med Toxicol. 2014 Mar 10;9(1):8. doi: 10.1186/1745-6673-9-8.

Working under the influence of drugs and/or alcohol may affect safety and job performance. However, the size of this possible problem among health professionals (HPs) is unknown. The aim of this study was threefold: (i) to analyze samples of...

Cite
Edvardsen HM, Karinen R, Moan IS, et al. Use of alcohol and drugs among health professionals in Norway: a study using data from questionnaires and samples of oral fluid. J Occup Med Toxicol. 2014;9(1):8doi: 10.1186/1745-6673-9-8.
Edvardsen, H. M., Karinen, R., Moan, I. S., Oiestad, E. L., Christophersen, A. S., & Gjerde, H. (2014). Use of alcohol and drugs among health professionals in Norway: a study using data from questionnaires and samples of oral fluid. Journal of occupational medicine and toxicology (London, England), 9(1), 8. https://doi.org/10.1186/1745-6673-9-8
Edvardsen, Hilde Marie Erøy, et al. "Use of alcohol and drugs among health professionals in Norway: a study using data from questionnaires and samples of oral fluid." Journal of occupational medicine and toxicology (London, England) vol. 9,1 (2014): 8. doi: https://doi.org/10.1186/1745-6673-9-8
Edvardsen HM, Karinen R, Moan IS, Oiestad EL, Christophersen AS, Gjerde H. Use of alcohol and drugs among health professionals in Norway: a study using data from questionnaires and samples of oral fluid. J Occup Med Toxicol. 2014 Mar 10;9(1):8. doi: 10.1186/1745-6673-9-8. PMID: 24612541; PMCID: PMC3973962.
Copy Download .nbib Format: NLM
First feed affects the expressions of microRNA and their targets in Atlantic cod - CORRIGENDUM.

The British journal of nutrition

Bizuayehu TT, Furmanek T, Karlsen Ø, van der Meeren T, Edvardsen RB, Rønnestad I, Hamre K, Johansen SD, Babiak I.
PMID: 26996320
Br J Nutr. 2016 May 28;115(10):1885. doi: 10.1017/S0007114516001276. Epub 2016 Mar 21.

No abstract available.

Cite
Bizuayehu TT, Furmanek T, Karlsen Ø, et al. First feed affects the expressions of microRNA and their targets in Atlantic cod - CORRIGENDUM. Br J Nutr. 2016;115(10):1885doi: 10.1017/S0007114516001276.
Bizuayehu, T. T., Furmanek, T., Karlsen, �. �., van der Meeren, T., Edvardsen, R. B., Rønnestad, I., Hamre, K., Johansen, S. D., & Babiak, I. (2016). First feed affects the expressions of microRNA and their targets in Atlantic cod - CORRIGENDUM. The British journal of nutrition, 115(10), 1885. https://doi.org/10.1017/S0007114516001276
Bizuayehu, Teshome Tilahun, et al. "First feed affects the expressions of microRNA and their targets in Atlantic cod - CORRIGENDUM." The British journal of nutrition vol. 115,10 (2016): 1885. doi: https://doi.org/10.1017/S0007114516001276
Bizuayehu TT, Furmanek T, Karlsen Ø, van der Meeren T, Edvardsen RB, Rønnestad I, Hamre K, Johansen SD, Babiak I. First feed affects the expressions of microRNA and their targets in Atlantic cod - CORRIGENDUM. Br J Nutr. 2016 May 28;115(10):1885. doi: 10.1017/S0007114516001276. Epub 2016 Mar 21. PMID: 26996320.
Copy Download .nbib Format: NLM
Quality of Life, Exercise Capacity and Comorbidity in Old Patients with Permanent Atrial Fibrillation.

Journal of atrial fibrillation

Ariansena I, Gjesdala K, Abdelnoorb M, Edvardsenc E, Engerd S, Tveitd A.
PMID: 28496601
J Atr Fibrillation. 2008 Dec 01;1(4):136. doi: 10.4022/jafib.136. eCollection 2008 Dec.

RESULTS: 27 subjects with permanent AF and 71 subjects in sinus rhythm participated. AF patients had higher prevalence of compensated chronic heart failure (p < 0.001), valvular heart disease (p < 0.001), lower mean VO2 peak (22.7 ± 5.5...

Cite
Ariansena I, Gjesdala K, Abdelnoorb M, et al. Quality of Life, Exercise Capacity and Comorbidity in Old Patients with Permanent Atrial Fibrillation. J Atr Fibrillation. 2008;1(4):136doi: 10.4022/jafib.136.
Ariansena, I., Gjesdala, K., Abdelnoorb, M., Edvardsenc, E., Engerd, S., & Tveitd, A. (2008). Quality of Life, Exercise Capacity and Comorbidity in Old Patients with Permanent Atrial Fibrillation. Journal of atrial fibrillation, 1(4), 136. https://doi.org/10.4022/jafib.136
Ariansena, Inger, et al. "Quality of Life, Exercise Capacity and Comorbidity in Old Patients with Permanent Atrial Fibrillation." Journal of atrial fibrillation vol. 1,4 (2008): 136. doi: https://doi.org/10.4022/jafib.136
Ariansena I, Gjesdala K, Abdelnoorb M, Edvardsenc E, Engerd S, Tveitd A. Quality of Life, Exercise Capacity and Comorbidity in Old Patients with Permanent Atrial Fibrillation. J Atr Fibrillation. 2008 Dec 01;1(4):136. doi: 10.4022/jafib.136. eCollection 2008 Dec. PMID: 28496601; PMCID: PMC5398808.
Copy Download .nbib Format: NLM
Republished article: Imaging assessment of ventricular mechanics.

Postgraduate medical journal

Edvardsen T, Haugaa KH.
PMID: 22262782
Postgrad Med J. 2012 Feb;88(1036):105-12. doi: 10.1136/pgmj.2009.184390rep.

No abstract available.

Cite
Edvardsen T, Haugaa KH. Republished article: Imaging assessment of ventricular mechanics. Postgrad Med J. 2012;88(1036):105-12doi: 10.1136/pgmj.2009.184390rep.
Edvardsen, T., & Haugaa, K. H. (2012). Republished article: Imaging assessment of ventricular mechanics. Postgraduate medical journal, 88(1036), 105-12. https://doi.org/10.1136/pgmj.2009.184390rep
Edvardsen, Thor, and Haugaa, Kristina H. "Republished article: Imaging assessment of ventricular mechanics." Postgraduate medical journal vol. 88,1036 (2012): 105-12. doi: https://doi.org/10.1136/pgmj.2009.184390rep
Edvardsen T, Haugaa KH. Republished article: Imaging assessment of ventricular mechanics. Postgrad Med J. 2012 Feb;88(1036):105-12. doi: 10.1136/pgmj.2009.184390rep. PMID: 22262782.
Copy Download .nbib Format: NLM
Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology.

ESC heart failure

Lancellotti P, Galderisi M, Donal E, Edvardsen T, Popescu BA, Farmakis D, Filippatos G, Habib G, Lestuzzi C, Santoro C, Moonen M, Jerusalem G, Andarala M, Anker SD.
PMID: 28772051
ESC Heart Fail. 2017 Aug;4(3):312-318. doi: 10.1002/ehf2.12162. Epub 2017 May 02.

AIMS: European Association of Cardiovascular Imaging/Heart Failure Association Cardiac Oncology Toxicity Registry was launched in October 2014 as a European Society of Cardiology multicentre registry of breast cancer patients referred to imaging laboratories for routine surveillance, suspected, or confirmed...

Cite
Lancellotti P, Galderisi M, Donal E, et al. Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology. ESC Heart Fail. 2017;4(3):312-318doi: 10.1002/ehf2.12162.
Lancellotti, P., Galderisi, M., Donal, E., Edvardsen, T., Popescu, B. A., Farmakis, D., Filippatos, G., Habib, G., Lestuzzi, C., Santoro, C., Moonen, M., Jerusalem, G., Andarala, M., Anker, S. D. (2017). Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology. ESC heart failure, 4(3), 312-318. https://doi.org/10.1002/ehf2.12162
Lancellotti, Patrizio, et al. "Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology." ESC heart failure vol. 4,3 (2017): 312-318. doi: https://doi.org/10.1002/ehf2.12162
Lancellotti P, Galderisi M, Donal E, Edvardsen T, Popescu BA, Farmakis D, Filippatos G, Habib G, Lestuzzi C, Santoro C, Moonen M, Jerusalem G, Andarala M, Anker SD. Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology. ESC Heart Fail. 2017 Aug;4(3):312-318. doi: 10.1002/ehf2.12162. Epub 2017 May 02. PMID: 28772051; PMCID: PMC5542718.
Copy Download .nbib Format: NLM
From talented child to elite athlete: The development of cardiac morphology and function in a cohort of endurance athletes from age 12 to 18.

European journal of preventive cardiology

Bjerring AW, Landgraff HE, Leirstein S, Haugaa KH, Edvardsen T, Sarvari SI, Hallén J.
PMID: 33611558
Eur J Prev Cardiol. 2020 Apr 29; doi: 10.1177/2047487320921317. Epub 2020 Apr 29.

BACKGROUND: Adult athletes undergo cardiac adaptions in what is known as the "athlete's heart". Cardiac adaptations in young athletes have not been described in longitudinal studies but have previously been believed to be uniform in nature.METHODS: Seventy-six cross-country skiers...

Cite
Bjerring AW, Landgraff HE, Leirstein S, et al. From talented child to elite athlete: The development of cardiac morphology and function in a cohort of endurance athletes from age 12 to 18. Eur J Prev Cardiol. 2020;doi: 10.1177/2047487320921317.
Bjerring, A. W., Landgraff, H. E., Leirstein, S., Haugaa, K. H., Edvardsen, T., Sarvari, S. I., & Hallén, J. (2020). From talented child to elite athlete: The development of cardiac morphology and function in a cohort of endurance athletes from age 12 to 18. European journal of preventive cardiology, . https://doi.org/10.1177/2047487320921317
Bjerring, Anders W, et al. "From talented child to elite athlete: The development of cardiac morphology and function in a cohort of endurance athletes from age 12 to 18." European journal of preventive cardiology vol. (2020). doi: https://doi.org/10.1177/2047487320921317
Bjerring AW, Landgraff HE, Leirstein S, Haugaa KH, Edvardsen T, Sarvari SI, Hallén J. From talented child to elite athlete: The development of cardiac morphology and function in a cohort of endurance athletes from age 12 to 18. Eur J Prev Cardiol. 2020 Apr 29; doi: 10.1177/2047487320921317. Epub 2020 Apr 29. PMID: 33611558.
Copy Download .nbib Format: NLM
Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity.

Brain : a journal of neurology

Ezer S, Daana M, Park JH, Yanovsky-Dagan S, Nordström U, Basal A, Edvardson S, Saada A, Otto M, Meiner V, Marklund SL, Andersen PM, Harel T.
PMID: 34788402
Brain. 2021 Nov 11; doi: 10.1093/brain/awab416. Epub 2021 Nov 11.

Pathogenic variants in SOD1, encoding superoxide dismutase 1, are responsible for about 20% of all familial amyotrophic lateral sclerosis cases, through a gain-of-function mechanism. Recently, two reports showed that a specific homozygous SOD1 loss-of-function variant is associated with an...

Cite
Ezer S, Daana M, Park JH, et al. Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity. Brain. 2021;doi: 10.1093/brain/awab416.
Ezer, S., Daana, M., Park, J. H., Yanovsky-Dagan, S., Nordström, U., Basal, A., Edvardson, S., Saada, A., Otto, M., Meiner, V., Marklund, S. L., Andersen, P. M., & Harel, T. (2021). Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity. Brain : a journal of neurology, . https://doi.org/10.1093/brain/awab416
Ezer, Shlomit, et al. "Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity." Brain : a journal of neurology vol. (2021). doi: https://doi.org/10.1093/brain/awab416
Ezer S, Daana M, Park JH, Yanovsky-Dagan S, Nordström U, Basal A, Edvardson S, Saada A, Otto M, Meiner V, Marklund SL, Andersen PM, Harel T. Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity. Brain. 2021 Nov 11; doi: 10.1093/brain/awab416. Epub 2021 Nov 11. PMID: 34788402.
Copy Download .nbib Format: NLM
Reduced Cardiac Function by Echocardiography in a Minority of COVID-19 Patients 3 Months after Hospitalization.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography

Tangen J, Aukrust P, Barratt-Due A, Skulstad H, Edvardsen T.
PMID: 34758386
J Am Soc Echocardiogr. 2021 Nov 07; doi: 10.1016/j.echo.2021.10.014. Epub 2021 Nov 07.

No abstract available.

Cite
Tangen J, Aukrust P, Barratt-Due A, et al. Reduced Cardiac Function by Echocardiography in a Minority of COVID-19 Patients 3 Months after Hospitalization. J Am Soc Echocardiogr. 2021;doi: 10.1016/j.echo.2021.10.014.
Tangen, J., Aukrust, P., Barratt-Due, A., Skulstad, H., & Edvardsen, T. (2021). Reduced Cardiac Function by Echocardiography in a Minority of COVID-19 Patients 3 Months after Hospitalization. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, . https://doi.org/10.1016/j.echo.2021.10.014
Tangen, Jorun, et al. "Reduced Cardiac Function by Echocardiography in a Minority of COVID-19 Patients 3 Months after Hospitalization." Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography vol. (2021). doi: https://doi.org/10.1016/j.echo.2021.10.014
Tangen J, Aukrust P, Barratt-Due A, Skulstad H, Edvardsen T. Reduced Cardiac Function by Echocardiography in a Minority of COVID-19 Patients 3 Months after Hospitalization. J Am Soc Echocardiogr. 2021 Nov 07; doi: 10.1016/j.echo.2021.10.014. Epub 2021 Nov 07. PMID: 34758386; PMCID: PMC8572552.
Copy Download .nbib Format: NLM
The c-di-AMP signaling system influences stress tolerance and biofilm formation of Streptococcus mitis.

MicrobiologyOpen

Rørvik GH, Naemi AO, Edvardsen PKT, Simm R.
PMID: 34459556
Microbiologyopen. 2021 Aug;10(4):e1203. doi: 10.1002/mbo3.1203.

Streptococcus mitis is a commensal bacterial species of the oral cavity, with the potential for opportunistic pathogenesis. For successful colonization, S. mitis must be able to adhere to surfaces of the oral cavity and survive and adapt to frequently...

Cite
Rørvik GH, Naemi AO, Edvardsen PKT, et al. The c-di-AMP signaling system influences stress tolerance and biofilm formation of Streptococcus mitis. Microbiologyopen. 2021;10(4):e1203doi: 10.1002/mbo3.1203.
Rørvik, G. H., Naemi, A. O., Edvardsen, P. K. T., & Simm, R. (2021). The c-di-AMP signaling system influences stress tolerance and biofilm formation of Streptococcus mitis. MicrobiologyOpen, 10(4), e1203. https://doi.org/10.1002/mbo3.1203
Rørvik, Gro Herredsvela, et al. "The c-di-AMP signaling system influences stress tolerance and biofilm formation of Streptococcus mitis." MicrobiologyOpen vol. 10,4 (2021): e1203. doi: https://doi.org/10.1002/mbo3.1203
Rørvik GH, Naemi AO, Edvardsen PKT, Simm R. The c-di-AMP signaling system influences stress tolerance and biofilm formation of Streptococcus mitis. Microbiologyopen. 2021 Aug;10(4):e1203. doi: 10.1002/mbo3.1203. PMID: 34459556; PMCID: PMC8289670.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 100 entries